![]() |
Volumn 20, Issue 4, 2002, Pages 807-812
|
B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B7 ANTIGEN;
CD86 ANTIGEN;
CD86 PROTEIN, MOUSE;
LEUKOCYTE ANTIGEN;
MEMBRANE PROTEIN;
PRIMER DNA;
RNA;
ANIMAL;
ARTICLE;
BRAIN TUMOR;
C57BL MOUSE;
CANCER TRANSPLANTATION;
CD4+ T LYMPHOCYTE;
CELL CULTURE;
CHEMISTRY;
COMPARATIVE STUDY;
FEMALE;
FLOW CYTOMETRY;
GENE THERAPY;
GENETIC TRANSFECTION;
GENETICS;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
METABOLISM;
MOUSE;
POLYMERASE CHAIN REACTION;
SURVIVAL RATE;
T CELL LYMPHOMA;
TUMOR ASSOCIATED LEUKOCYTE;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD80;
ANTIGENS, CD86;
BRAIN NEOPLASMS;
CD4-POSITIVE T-LYMPHOCYTES;
DNA PRIMERS;
FEMALE;
FLOW CYTOMETRY;
GENE THERAPY;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTES, TUMOR-INFILTRATING;
LYMPHOMA, T-CELL;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED C57BL;
NEOPLASM TRANSPLANTATION;
POLYMERASE CHAIN REACTION;
RNA;
SURVIVAL RATE;
TRANSFECTION;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
EID: 0036551282
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.20.4.807 Document Type: Article |
Times cited : (15)
|
References (0)
|